semaglutide action Why is Everyone Talking About the 'Glutide' Drugs as a Treatment for Obesity? Designing GLP-1 delivery: structural perspectives

Clinical trials showed A1c reductions of ~0.8%1.0% with albiglutide, a bit less than other GLP-1 RAs, but still significant

In the short term, the Centers for Medicare and Medicaid Services, the federal agency that administers Medicare and partners with state governments to manage Medicaid, is testing what would happen if Medicare Part D covered GLP-1s for obesity to get a sense for how much it would cost, and what those positive externalities might be

We have no direct ATP measurements in human peripheral epithelial tissue during retatrutide therapy

Hepatology 69 , 24142426 (2019)

The presence of congenital or acquired malabsorption syndromes, such as coeliac disease or tropical sprue, will affect absorption, and gastric stasis, whether as a result of trauma or drugs, slows the transit time through the gut